Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Anti Obesity Medications in Patients With Heart Failure: Current Evidence and Practical Guidance Circulation: Heart Failure Cagrilintide 10mg Prime Lab Peptides Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Semaglutide vs Tirzepatide, Cagrilintide, and Retatrutide: Mechanisms & Research Insights